Ratigan Emmett, Kasimsetty Sashi, Cohen Jeffrey, Shigeoka Alana, Stocks Lisa, Mekeel Kristin, Steiner Robert, McKay Dianne B
Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA, USA.
J Oncol Res Ther. 2019;4(1). Epub 2019 Feb 19.
Hypothermic Machine Perfusion (HMP) has been shown to decrease Delayed Graft Function (DGF) and improve outcomes of deceased donor kidney transplants. Although the mechanisms of protection afforded by HMP have not yet been defined, this study tested the hypothesis that HMP improves transplant outcomes by clearing pro-inflammatory molecules from the allograft during pumping. Here we report on 26 allografts preserved via pulsatile HMP at our organ procurement organization that were prospectively evaluated for the time-dependent clearance of cytokines, chemokines and injury markers during their time on pump. Of the cytokines and chemokines measured, IL-1RA, IL-6, IL-18, INFγ, and MCP-1 were increased in the pump perfusate over time and were correlated with markers of kidney injury. Over time on pump, the 'Danger' molecule HMGB1 appeared in the perfusate, and perfusate samples activated T-cells . The data from this prospective study show that HMP is associated with a time-dependent clearance of pro-inflammatory cytokines, chemokines and danger molecules from donor allografts during the process of pumping, which may in part explain the beneficial effects of HMP.
低温机器灌注(HMP)已被证明可降低移植肾延迟功能恢复(DGF)并改善 deceased 供体肾移植的预后。尽管 HMP 提供保护的机制尚未明确,但本研究检验了这样一个假设,即 HMP 通过在灌注过程中从同种异体移植物中清除促炎分子来改善移植预后。在此,我们报告了在我们的器官获取组织中通过搏动性 HMP 保存的 26 个同种异体移植物,这些移植物在灌注期间对细胞因子、趋化因子和损伤标志物的时间依赖性清除进行了前瞻性评估。在所测量的细胞因子和趋化因子中,随着时间的推移,泵灌注液中的白细胞介素 -1 受体拮抗剂(IL-1RA)、白细胞介素 -6(IL-6)、白细胞介素 -18(IL-18)、干扰素γ(INFγ)和单核细胞趋化蛋白 -1(MCP-1)增加,并且与肾损伤标志物相关。随着泵灌注时间的延长,“危险”分子高迁移率族蛋白 B1(HMGB1)出现在灌注液中,并且灌注液样本激活了 T 细胞。这项前瞻性研究的数据表明,HMP 在灌注过程中与从供体同种异体移植物中时间依赖性清除促炎细胞因子、趋化因子和危险分子有关,这可能部分解释了 HMP 的有益作用。